With Solvadi in the mix, the FDA's class of 2013 is set for chart-busting sales
10.03.2014 / Fierce Pharma
The number of new drugs approved by the FDA last year may have been down considerably but some of them were humdingers. Eight are projected to hit blockbuster status 5 years out, and the entire group of 33 is forecast to have fifth-year projected sales of $25.4 billion. That is 50% more than the record breaking group of 43 drugs approved in 2012.